Ertaczo (Sertaconazole) is hard to find in 2026. Learn why this antifungal cream has limited availability and what you can do to get your prescription filled.
You walked into your pharmacy expecting to pick up your Ertaczo prescription — and they told you it's not in stock. You tried another pharmacy. Same story. Now you're wondering: is Ertaczo discontinued? Is there a shortage? What's going on?
You're not imagining things. Ertaczo (Sertaconazole Nitrate) cream has become increasingly difficult to find at pharmacies across the United States. In this article, we'll explain exactly why Ertaczo is so hard to find in 2026 and what steps you can take to get the medication you need.
Ertaczo is a prescription topical antifungal cream containing 2% Sertaconazole Nitrate. It belongs to the azole (imidazole) class of antifungals and was first approved by the FDA in 2003 for the treatment of interdigital tinea pedis — commonly known as athlete's foot — in patients 12 years of age and older.
What makes Ertaczo unique is its dual mechanism of action. It works by blocking an enzyme called cytochrome P450 14-alpha-demethylase, which fungi need to build their cell membranes. It also directly binds to fungal cell membrane lipids, causing the membrane to break down. This two-pronged attack makes it effective against several types of fungi including Trichophyton rubrum, Trichophyton mentagrophytes, and Epidermophyton floccosum.
Doctors also sometimes prescribe Ertaczo off-label for other fungal skin conditions like ringworm (tinea corporis), jock itch (tinea cruris), and tinea versicolor. To learn more about how this medication works, check out our guide on how Ertaczo works.
There are several reasons why you might struggle to fill an Ertaczo prescription in 2026:
Unlike many other topical antifungals, Ertaczo does not have a generic equivalent available in the United States. This means there is only one manufacturer producing this medication. When you have a single source for any drug, supply disruptions become more likely and more impactful. Most pharmacies stock medications based on demand, and with no generic competition, Ertaczo has a smaller market footprint than alternatives like Clotrimazole or Terbinafine.
The retail price of Ertaczo is steep — typically between $897 and $1,070 for a single tube without insurance. At that price point, many pharmacies choose not to keep it on their shelves because it ties up significant inventory dollars for a product that doesn't move quickly. Chain pharmacies in particular may not stock it unless they have a confirmed prescription waiting.
Ertaczo is distributed by Coral Way Pharma, LLC and manufactured by DPT Laboratories in San Antonio, Texas. As a niche brand product, its distribution channels are narrower than those of mass-market antifungals. Not every pharmacy wholesaler carries it consistently, which can lead to gaps in availability at the retail level.
Many insurance plans require prior authorization or step therapy before covering Ertaczo. This means your insurer may want you to try cheaper over-the-counter options like Clotrimazole (Lotrimin) or Terbinafine (Lamisil) first. Because fewer patients end up filling Ertaczo prescriptions, pharmacies have even less incentive to keep it in stock. For tips on managing the cost, see our article on how to save money on Ertaczo.
Even though Ertaczo can be tricky to locate, there are practical steps you can take:
The fastest way to find Ertaczo near you is to use Medfinder. Medfinder checks real-time stock at pharmacies in your area so you don't have to call around. Just search for Ertaczo and see which pharmacies near you currently have it available.
Independent pharmacies often have more flexibility in their ordering than big chains. They may be able to special-order Ertaczo for you directly from the wholesaler. Compounding pharmacies might also be able to prepare a Sertaconazole formulation if your doctor is open to that option.
If your preferred pharmacy doesn't have Ertaczo in stock, ask them to order it for you. Many pharmacies can get it within 1-3 business days through their wholesaler. Just be sure to confirm the price before they order, especially if you're paying out of pocket.
If you simply can't find Ertaczo or can't afford it, your doctor may recommend an alternative antifungal. Options like Terbinafine (Lamisil), Clotrimazole (Lotrimin), Naftifine (Naftin), or Luliconazole (Luzu) treat similar conditions. Read our full guide on alternatives to Ertaczo for more details.
Even without insurance, discount cards from GoodRx, SingleCare, and SaveHealth can reduce the price of Ertaczo significantly — sometimes to around $447 to $897 depending on the pharmacy. Check our savings guide for the latest coupons.
No, Ertaczo is not discontinued. It remains an FDA-approved medication that is actively manufactured and distributed. However, its limited availability can make it feel like it's been pulled from the market. If a pharmacy tells you they can't get it, that usually means their particular wholesaler is temporarily out — not that the drug has been discontinued.
Finding Ertaczo in 2026 requires a bit more effort than picking up a common prescription, but it's far from impossible. The main challenges — no generic, high cost, limited distribution, and insurance barriers — are all things you can work around with the right approach.
Start by checking availability on Medfinder, talk to your pharmacist about ordering options, and have a conversation with your doctor about alternatives if needed. For a deeper dive into the current supply situation, read our Ertaczo shortage update for 2026.
You deserve to get the treatment your doctor prescribed. Don't give up — the right pharmacy is out there.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
